Cure Today

Performance Status Associated With Patient-Reported Outcomes in Gastric/GEJ Adenocarcinoma

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
ascopubs.org

Inclusion of patients with reduced performance status (ECOG 2 or higher) in FDA registrational trials for renal cell carcinoma (RCC).

Ethnic disparities in clinical trials for FDA-approved drugs in renal cell carcinoma: An analysis in the post-COVID-19-era (2020-2024). LITESPARK-005, KEYNOTE-564, TIVO-3, CLEAR, CHECKMATE-9ER, ...
The American Journal of Managed Care

Real-World Evidence Supports Chemoimmunotherapy in ES-SCLC With Poor PS

Incorporating ICIs into platinum-doublet regimens improved OS and ORR in ES-SCLC patients with ECOG PS 2 to 3, but not in those with ECOG PS 0 to 1. The study found manageable adverse reactions, with ...
ascopubs.org

Clinical Outcomes of Patients With Metastatic Colorectal Cancer Treated With Trifluridine-Tipiracil + Bevacizumab by Performance Status

Tumor-Targeted IL-12 (PDS01ADC) With Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Nonrandomized Phase II Trial Patients with mCRC exposed to FTD-TPI + ...